健保藥品的HTA評估報告
- 201 朗斯弗®膜衣錠15毫克/20毫克(LONSURF® Film-Coated Tablet 15mg/20mg)
- 202 英可欣膜衣錠15毫克、英可欣膜衣錠45毫克(Iclusig 15mg film-coated tablets、Iclusig 45mg film-coated tablets)
- 203 鐳治骨注射液(Xofigo)
- 204 瑪力優凍晶注射劑25毫克(TuNEX 25mg powder and solvent for injection)
- 205 TuNEX 25mg powder and solvent for injection
- 206 Rytmonorm SR 225mg、325mg、425mg Capsules
- 207 立美西膚皮下注射劑210毫克(Lumicef subcutaneous Injection 210mg Syringe)
- 208 特諾雅注射液(Tremfya Solution for Injection 100mg)
- 209 波賽特農縮輸注液18毫克/毫升(posanol 18mg/mL Concentrate for Solution for infusion)
- 210 欣瘤伏長效緩釋注射劑20/40/60毫克(Signifor LAR 20mg、40mg、60mg powder and solvent for suspension for injection 等3品項)
- 211 克雷葛膜衣錠100毫克, 200毫克, 400毫克(Inovelon Film-coated Tablets 100mg, 200mg, 400mg)
- 212 Vimizim 5mg/vial injection
- 213 比樂舒活錠200毫克(Pirespa Tablets 200mg)
- 214 億珂®膠囊140毫克(Imbruvica® Capsules 140mg)
- 215 賀肝樂膜衣錠(Zepatier tablet)
- 216 莫須瘤皮下注射劑(Mabthera solution for subcutaneous injection)
- 217 異位寧(Visanne)
- 218 捷扶康膜衣錠(Genvoya film coated tablets)
- 219 耐比洛錠5毫克(Nebilet 5mg)
- 220 艾拉特凍晶注射劑(Eloctate powder for injection)